Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
1732 participants
INTERVENTIONAL
2021-12-29
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Targeted Education for Atrial Fibrillation Patients (Application Substudy)
NCT03788044
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080
Effect of Targeted Education for Atrial Fibrillation Patients
NCT03707873
Atrial Fibrillation Screening and Education Study
NCT03440762
NURSE-led Follow-up in Patients Undergoing CATheter Ablation for Atrial Fibrillation
NCT05333445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention arm: A 16-week blended learning programme targeting stroke prevention and rhythm control therapy at the healthcare professional level, with controlled assessments, a commitment to change plan, and reinforcement actions Control arm: No added education of healthcare professionals 70 centres with a cluster size of 25 patients; total estimated number of patients 1750.
8-12 weeks patient recruitment period at each centre; 16 weeks educational intervention period; primary \& secondary outcomes at 6-9 months post-randomisation; remote follow-up for clinical events (no new patient contact) at 18 months from randomisation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
A 16-week blended learning programme targeting stroke prevention and rhythm control therapy at the healthcare professional level, with controlled assessments, a commitment to change plan, and reinforcement actions
Education
Randomization between two groups at site level. One cluster with education and one without.
Control arm
No added education of healthcare professionals
Education
Randomization between two groups at site level. One cluster with education and one without.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Randomization between two groups at site level. One cluster with education and one without.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consents to data collection at baseline and follow-up.
Exclusion Criteria
* Pregnant or planning pregnancy,
* Participating in another clinical trial of an investigational medicinal product or device,
* Life expectancy of less than 2 years.
Patient assessment: Baseline (time of recruitment) and at follow-up routine appointment (6-9 months), plus remote follow-up at 18 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Birmingham
OTHER
European Society of Cardiology
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hein Heidbuchel
Role: STUDY_CHAIR
Universiteit Antwerpen
Dipak Kotecha
Role: STUDY_DIRECTOR
University of Birmingham
Isabelle van Gelder
Role: STUDY_DIRECTOR
University Medical Center Groningen, The Netherlands
Serge Boveda
Role: PRINCIPAL_INVESTIGATOR
Clinique Pasteur, France
Philipp Sommer
Role: PRINCIPAL_INVESTIGATOR
Ruhr-Universität Bochum, Germany
Giuseppe Boriani
Role: PRINCIPAL_INVESTIGATOR
University of Modena & Reggio Emilia
Maciej Sterliński
Role: PRINCIPAL_INVESTIGATOR
National Institute of Cardiology, Warsaw, Poland
Luis Mont
Role: PRINCIPAL_INVESTIGATOR
University of Barcelona, Spain
Kim Rajappan
Role: PRINCIPAL_INVESTIGATOR
University of Oxford, UK
Eduard Guasch
Role: PRINCIPAL_INVESTIGATOR
University of Barcelona, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Rennes
Rennes, 'Ille-et-Vilaine, Brittany, France
CHU La Timone
Marseille, Bouches-du-Rhône, France
CHU Dijon - Hôpital du Bocage
Dijon, Burgundy, France
Hôpital Cardiologique du Haut-Lévèque
Pessac, Gironde, Nouvelle-Aquitaine, France
CHU Dupuytren
Limoges, Haute-Vienne, France
CHU Nancy, Hôpitaux de Brabois
Nancy, Meurthe-et-Moselle (Lorraine), France
CHU Rouen
Rouen, Normandy, France
CHU Rangueil
Toulouse, Occitanie, Haute-Garonne, France
CHU Poitiers
Poitiers, Poitou-Charentes, France
CHU Aix en Provence
Aix-en-Provence, Provence-Alpes-Côte d'Azur Region, France
Centre Hospitalier de Pau
Pau, Pyrénées-Atlantiques, France
CHI Toulon La Seyne-sur-Mer Sainte Musse
Toulon, Var, France
Hôpital Henri Mondor (APHP)
Créteil, Île-de-France Region, France
CHU Pitié-Salpetrière
Paris, Île-de-France Region, France
Centre Cardiologique du Nord (CCN)
Saint-Denis, Île-de-France Region, France
University Hospital Würzburg
Würzburg, Bavaria, Germany
Segeberger Kliniken GmbH
Bad Segeberg, chleswig-Holstein, Germany
Herzzentrum Niederrhein Krefeld
Krefeld, North Rhine-Westphalia, Germany
Heart Centre Bad Neustadt
Neustadt, Rhineland-Palatinate, Germany
Praxisklinik Herz Und Gefässe
Dresden, Saxony, Germany
Heart Center Leipzig, University of Leipzig
Leipzig, Saxony, Germany
Herz Riesa
Riesa, Saxony, Germany
Asklepios Klinik St. Georg
Hamburg, , Germany
Heart Center University Hamburg
Hamburg, , Germany
Medizinische Hochschule Hannover, MHH
Hanover, , Germany
Universitätsklinikum Schleswig-Holstein Lübeck
Lübeck, , Germany
Federico II University Hospital
Naples, Campania, Italy
S Orsola-Malpighi University Hospital
Bologna, Emilia-Romagna, Italy
Sant'Anna University Hospital of Ferrara
Ferrara, Emilia-Romagna, Italy
Policlinico di Modena, University of Modena and Reggio Emilia
Modena, Emilia-Romagna, Italy
Cardiologia Orvieto
Orvieto, Terni, Italy
University of Florence & AOU Careggi
Florence, Tuscany, Italy
Clinica Aritmologica, Universita Politecnica delle Marche
Ancona, , Italy
Cardiology Unit Borgo San Lorenzo and Serristori
Florence, , Italy
Toruń Hospital
Torun, Vistula Rive, Poland
District Chojnice Hospital
Chojnice, , Poland
Scanmed Cardiology Center
Ełk, , Poland
Centrum Opieki Medycznej w Jaroslawiu
Jarosław, , Poland
Polikliniką SPZOZ w Lublinie
Lublin, , Poland
Przasnysz
Przasnysz, , Poland
Pułtusk
Pułtusk, , Poland
Siedlce 2 Hospital
Siedlce, , Poland
Wojewódzki Szpital Specjalistyczny nr 5 im
Sosnowiec, , Poland
Szpital Wojewodzki in Sw. Lukasza / Regional Specialist Hospital
Tarnów, , Poland
Wegrow Hospital
Węgrów, , Poland
Lukow
Łuków, , Poland
Hospital Universitario Puerta del Mar
Seville, Andalusia, Spain
Virgen del Rocio University Hospital
Seville, Andalusia, Spain
Hospital Miguel Servet
Zaragoza, Aragon, Spain
Hospital Vall d'Hebron
Barcelona, Catalonia, Spain
Hospital Universitari de Bellvitge
Barcelona, Catalonia, Spain
Hospital Germans Trias i Pujol
Barcelona, Catalonia, Spain
Hospital Universitari Doctor Josep Trueta
Girona, Catalonia, Spain
Hospital General Universitario de Alicante
Alicante, Valencian, Spain
Hospital Universitario La Paz
Madrid, , Spain
Hospital La Fe.com.Valencianna
Valencia, , Spain
Hospital Gral Vigo, Galicia
Vigo, , Spain
Buckinghamshire Healthcare NHS Trust - Wycombe Hospital
Buckingham, Buckinghamshire, United Kingdom
Norwich Hospital
Norwich, East of England, United Kingdom
Gloucestershire Royal Hospital
Gloucester, England, United Kingdom
Homerton Hospital
London, England, United Kingdom
St Bartholomew's Hospital
London, England, United Kingdom
Imperial College London Chelsea and Westminster Hospital NHS foundation
London, England, United Kingdom
James Cook University Hospital
Middlesbrough, England, United Kingdom
Northampton General Hospital
Northampton, England, United Kingdom
Royal Berkshire foundation NHS trust
Reading, England, United Kingdom
York Hospital
York, North Yorkshire, United Kingdom
Horton General Hospital
Banbury, River Cherwell in Oxfordshire, United Kingdom
Royal Devon and Exeter NHS Foundation Trust
Exeter, West England, United Kingdom
Queen Elizabeth II
Birmingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kotecha D, Bunting KV, Mehta S, Sommer P, Sterlinski M, Rajappan K, Mont L, Guasch E, Boveda S, Boriani G, Sun Y, van Deutekom C, Gale CP, De Potter TJR, van Gelder IC; STEEER-AF investigators. Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial. Nat Med. 2025 Aug;31(8):2647-2654. doi: 10.1038/s41591-025-03751-2. Epub 2025 Jun 13.
Sterlinski M, Bunting KV, Boriani G, Boveda S, Guasch E, Mont L, Rajappan K, Sommer P, Mehta S, Sun Y, Gale CP, van Deutekom C, Van Gelder IC, Kotecha D; STEEER-AF Trial Team. Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association. Europace. 2024 Jul 2;26(7):euae178. doi: 10.1093/europace/euae178.
Szymanski P, Weidinger F, Lordereau-Richard I, Himmelmann A, Arca M, Chaves J, Lee C, Jonker C, Kotecha D, O'Kelly J, Plueschke K, Rys A, Segec A, Wallentin L, Veltrop R, James S. Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency. Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):109-118. doi: 10.1093/ehjqcco/qcad009.
Banerjee A, Pasea L, Chung SC, Direk K, Asselbergs FW, Grobbee DE, Kotecha D, Anker SD, Dyszynski T, Tyl B, Denaxas S, Lumbers RT, Hemingway H. A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential. Eur J Heart Fail. 2022 Mar;24(3):466-480. doi: 10.1002/ejhf.2417. Epub 2022 Jan 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STEEER-AF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.